product summary
company name :
Developmental Studies Hybridoma Bank
product type :
antibody
product name :
Nuclear respiratory factor 1
catalog :
PCRP-NRF1-4A3
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
PCRP-NRF1-4A3
reactivity :
human
application :
western blot, immunoprecipitation
more info or order :
product information
Internal ID :
15217
Name :
PCRP-NRF1-4A3
Depositor Name :
Protein Capture Reagents Program, produced by JHU/CDI
Depositor Institution :
National Institutes of Health
Depositor Website :
http://proteincapture.org
Date Deposited :
1/8/15
Allow Hybridoma Distribution :
Yes
Cells Available (legacy) :
Yes
Antigen :
Nuclear respiratory factor 1
Antigen Species :
Human
Host Species :
mouse
Isotype :
MIgG2a
Positive Tested Species Reactivity :
Human
Initial Publication Pubmed ID :
29638227
Collections :
Human,Nucleus,Protein Capture Reagents,Transcription factors
Search Keywords :
Protein Capture Reagents Program, produced by JHU/CDI , Nuclear respiratory factor 1, Human, MIgG2a, Human, NRF1, ALPHA-PAL, EWG, , Monoclonal
Antigen Molecular Weight :
53.54 kDa
Gene :
NRF1
Alternate Gene Name(s) :
ALPHA-PAL, EWG
Uniprot ID :
Q16656
Antibody Registry ID :
AB_2618919
Immunogen :
Recombinant peptide
Immunogen Sequence :
a.a. 59-490
Clonality :
Monoclonal
Myeloma Strain :
SP2/0-Ag14
Epitope Mapped :
No
Recommended Applications :
Immunoprecipitation,Microarray,Western Blot
Depositor Growth Medium :
10% low IgG fetal bovine serum in DMEM with 1x pen/strep
Additional Information :
RRID: AB_2618919
DSHB Growth Medium :
Iscove's
more info or order :
company information
Developmental Studies Hybridoma Bank
review
product type
related products
browse more products
- OBFC1; Oligonucleotide/oligosaccharide-binding fold containing 1 | PCRP-OBFC1-1B4
- PBX4; Pre-B-cell leukemia homeobox 4 | PCRP-PBX4-1C11
- PBX4; Pre-B-cell leukemia homeobox 4 | PCRP-PBX4-1H1
- PGBD1; PiggyBac transposable element derived 1 | PCRP-PGBD1-3C5
- PGBD1; PiggyBac transposable element derived 1 | PCRP-PGBD1-4C8
questions and comments